Pattern of Compliance and Efficacy of Rtms Protocol for ...

Introduction: There has been a breakthrough in treating MDD since introduction of FDA approved repetitive transcranial magnetic stimulation (rTMS) ... Sun,Jun5,2022 [Archive] Rememberme CreateAccount ResetPassword Home JournalInformation AbouttheJournal EditorialBoard AimsandScopes Abstracting&Indexing JournalNews OpenAccessPolicy FinancialPolicies CrossMarkPolicy JournalMetrics Abstracting&Indexing JournalArchive AcceptedArticles CurrentIssue AllIssues SpecialIssueonCovid-19 ForAuthors CallforPaper InstructionsforAuthors ReferencesGuideline PrinciplesofPublishingEthics EthicalCodes:MedicalResearch EthicalCode:PsychologicStudy PoliciesofPeerReview ConflictofInterest ArticleProcessingCharges ForReviewers PoliciesofPeerReview Referees Contactus ContactInformation Contactus OnlineSubmission AcceptedArticles          Backtothearticleslist| Backtobrowseissuespage ‎ 10.32598/bcn.2021.3369.1 PatternofComplianceandEfficacyofRtmsProtocolforTreatingMajorDepressiveDisorder(MDD)AmongTreatmentParticipantsandCompleters:AReportfromIran JavadAlaghband-rad*1,MahtabMotamed1,ZahraKhazaeipour2,ParvanehFarhadbeigi3 1-PsychiatryDepartment,TehranUniversityofMedicalSciences,Tehran,Iran.2-BrainandSpinalCordInjuryResearchCenter,NeuroscienceInstitute,TehranUniversityofMedicalSciences,Tehran,Iran.3-AcademicCenterforEducation,CultureandResearch,AlborzBranches,Karaj,Iran. Abstract:  Introduction:TherehasbeenabreakthroughintreatingMDDsinceintroductionofFDAapprovedrepetitivetranscranialmagneticstimulation(rTMS)interventionin2008.However,themanysessionsoftreatmentanditscostmakesitinconvenientforthosewhoseektreatmentespeciallyinlargecitiesandalsoindevelopingcountries. Method:Atotalof22patients(outofinitial24referrals)whometDSMIVcriteriaforMDDwereenrolledintothestudy.Thesubjects allhadtofailatleastonepriortreatmentfordepression.ThepatientsreceivedtheFDAapprovedprotocolofhigh-frequency(10Hz)rTMSovertheleftdorsolateralprefrontalcortex. Results:Seventeencasesoutoftwenty-twocasesshowedsignificantimprovementsaftertwoweeksoftreatment.Onlysixpatientscontinuedtheirtreatmentsforthenexttwotofourweeks.  Conclusions:WehavereplicatedotherstudiesshowingthatusingrTMSis effectivewithnomajorsideeffectsformanypatientswithMDDandtheirimprovementsaremeasurablemostlyaftertwoweeks.OurdatahighlightstheimportanceofapplicationofmoreconvenientprotocolswhichrequirefewersessionsonfewerdaystohelpwithcomplianceandoutcomeparticularlyinlargepopulatedcitiesandcountrieslikeIrangoingthrougheconomichardship. Keywords:Depression,Rtms,Compliance,Outcome,Treatment Full-Text[PDF1914kb]       TypeofStudy:Original| Subject: ClinicalNeuroscienceReceived:2021/05/1|Accepted:2021/06/7 Addyourcommentsaboutthisarticle:YourusernameorEmail: Sendemailtothearticleauthor Rightsandpermissions ThisworkislicensedunderaCreativeCommonsAttribution-NonCommercial4.0InternationalLicense. ContactInformation BasicandClinicalNeuroscienceJournal(BCN) IranUniversityofMedicalSciences,ShahidHemmatHighway,Tehran,Iran. PublisherTel: +982145355555;+982145355000 (EXT:104) URL: http://bcn.iums.ac.ir/ PublisherEmail: infonirp.ir      ©2022CCBY-NC4.0|BasicandClinicalNeuroscience Designed&Developedby:Yektaweb